A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Clinical trial NCT03973775 · COMPLETED
Trial details
- NCT number
- NCT03973775
- Sponsor
- Saptalis Pharmaceuticals LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2018-11-13
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.